AXT updated its revenue outlook for the fourth quarter of fiscal 2025 to a range of $22.5 million to $23.5 million, citing delays in export control permits for its indium phosphide substrates from China’s Ministry of Commerce. Management noted that while permit timing remains fluid, customer demand for its compound semiconductor wafers continues to be robust, driven by AI infrastructure build-out and high-speed optical connectivity applications.

On January 9, 2026, a prominent firm issued a new valuation assessment implying roughly a 30% downside from current market levels, reflecting concerns that recent challenges may not be fully priced in. This represents the most conservative outlook among recent broker reports and underscores the need for investors to weigh export-permit uncertainty against the company’s long-term position in niche semiconductor materials.

Despite headwinds, AXT’s share volume surged past 11 million traded shares on NASDAQ, signaling heightened investor interest ahead of the upcoming earnings report. The company’s market capitalization now stands above $1.1 billion, cementing its status as a leading small-cap player in the compound semiconductor wafer substrate segment.

AXT will report fourth quarter results on February 19, 2026, immediately after market close, followed by a conference call at 1:30 p.m. PT, accessible via live webcast. The company will also present at the 28th Annual Needham Growth Conference on January 14, 2026, offering further insight into its capacity-expansion plans and execution milestones for its indium phosphide and gallium arsenide product lines.